FacebookXInstagramTelegram
WhatsApp! 020-122-280-6824

About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
30 06, 2025

Strongest Appetite Suppressant Over the Counter Now Available in USA – PhenQ Medically Accredited Craving Control Supplement OTC

By |2025-06-30T23:31:41+03:00June 30, 2025|Dietary Supplements News, News|0 Comments


Clinicians’ Choice Appetite Suppressant, PhenQ: Medically Accredited by 800 Professionals and Now Launched in the USA Without Prescription

Phenq

Get the latest news


delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Phenq


New York City, NY, June 30, 2025 (GLOBE NEWSWIRE) —  For Americans seeking the most effective, safe, and convenient way to control food cravings and promote weight loss, a breakthrough is here. 

PhenQ, the strongest appetite suppressant over the counter (OTC), has officially launched in the United States and worldwide-earning the rare and coveted “clinicians’ choice” status after being medically accredited by over 800 medical professionals.

For men and women looking to lose weight, manage appetite, and improve overall health without the risks of prescription appetite suppressants or weight loss drugs, PhenQ is the OTC appetite suppressant the world has been waiting for.

Product Launch: A New Era for Clinician-Backed OTC Appetite Suppressants

PhenQ’s arrival marks a turning point in the world of weight loss supplements. For decades, Americans have struggled to find effective appetite suppressant pills that are both safe and available without a prescription. 

Prescription appetite suppressants and weight loss drugs often require doctor supervision, can lead to high blood pressure, and may not be suitable for those with a higher body mass index or specific health concerns.

Now, with PhenQ, users can experience the best appetite suppressant over the counter, with a formula that has been medically accredited, approved, and recommended by over 800 clinicians. 

This level of medical endorsement is a rarity for OTC appetite suppressants, making PhenQ the clear leader in the category.

Main PhenQ Benefits & Features

PhenQ delivers a multi-faceted approach to weight loss and appetite control. Here’s what makes it the most effective appetite suppressant OTC and a top choice for weight management:

1. Clinically Proven Appetite Suppressant

PhenQ’s formula contains α-Lacys Reset®, a patented complex that accelerates metabolism and promotes thermogenesis, helping users suppress appetite and burn calories more efficiently. Clinical studies have shown that people using α-Lacys Reset® lost up to 7.24% of body fat, 3.44% of body weight, and gained 3.8% muscle mass, making it a unique weight loss supplement for those looking to lose weight while retaining lean muscle.

2. Reduces Food Cravings

Through its blend of chromium picolinate, nopal cactus, and natural caffeine, PhenQ helps reduce cravings for sweets and carbs. This powerful appetite suppressant formula is designed to help users stay on track, avoid emotional eating, and break the cycle of late-night snacking.

3. Promotes Weight Loss and Fat Burning

PhenQ combines thermogenic agents like Capsimax powder (a blend of capsicum, piperine, caffeine, and niacin) to ignite fat burning and help users reach their weight loss goals faster. This is not just an appetite suppressant, but a comprehensive weight loss supplement for total body transformation.

4. Enhances Energy and Mood

Unlike many diet pills or prescription appetite suppressants that can cause fatigue or mood swings, PhenQ contains caffeine, nopal, and L-carnitine to provide all-day energy and cognitive support. This keeps users motivated, focused, and ready to conquer their health and fitness journey.

5. Supports Normal Appetite and Keto Lifestyles

PhenQ is a natural appetite suppressant that fits perfectly into keto or low-carb diets, helping users manage appetite and maintain healthy eating habits for sustainable weight loss.

6. No Prescription Required-100% OTC

As one of the strongest OTC appetite suppressants, PhenQ is available for purchase without a prescription. This makes appetite control more accessible than ever for millions of Americans.

7. Vegan & Vegetarian Friendly

PhenQ is made from 100% vegan and vegetarian ingredients, ensuring inclusivity for a wide variety of dietary needs.

Company Name and Location

PhenQ (USA)

Wolfson Brands (UK) Limited

12 Payne Street, Glasgow, G4 0LF, United Kingdom

Distributed in the USA, Canada, UK, Australia and globally

PhenQ Pricing Details

PhenQ is competitively priced with attractive savings for multi-bottle purchases and includes a risk-free guarantee:

1 Bottle: $69.99 (Retail $79.99) – 1 Month Supply2 Bottles + 1 Free: $139.99 (Retail $239.99) – 3 Month Supply (Most Popular)3 Bottles + 2 Free: $209.99 (Retail $399.99) – 5 Month Supply (Best Value)Free Shipping: On all orders over $79.9960-Day Money-Back Guarantee: Try it risk-free Order and see current offers at official PhenQ website

Launch Date & Availability

PhenQ is now available to buy OTC in the United States and ships to over 190 countries. Orders are processed and shipped within 24-48 hours from warehouses in the US, UK, and Germany. PhenQ is also now available for purchase worldwide, providing rapid delivery and discreet packaging.

Scientific Data and Studies

PhenQ’s appetite suppressant formula is backed by clinical research:

α-Lacys Reset®: Clinical trials published in peer-reviewed journals demonstrate significant reductions in body weight, body fat, and increased muscle mass compared to placebo.Capsimax Powder: Research in Bioscience Report highlights the ability of capsaicinoids to increase thermogenesis and potentially stop the formation of new fat cells.Chromium Picolinate: An eight-week Cornell University study showed chromium supplementation helps reduce carb cravings and supports healthy blood sugar levels.Caffeine: Multiple studies confirm caffeine’s ability to suppress appetite, increase alertness, and boost metabolic rate.Nopal Cactus: Rich in fiber and amino acids, nopal helps manage appetite, increase satiety, and reduce fluid retention. References:

Whiting S, Derbyshire E, Tiwari BK. (2012) Appetite Control.Zemel MB, Thompson W, Milstead A, et al. (2004) Obesity Research.Docherty JP, Sack DA, et al. (2005) Journal of Psychiatry Practice. Health & Safety Benefits

PhenQ is designed as a safe, effective alternative to prescription appetite suppressants and weight loss drugs:

All-Natural Appetite Suppressant: PhenQ includes only natural, high-grade ingredients with a strong safety record.No Major Side Effects: No prescription required, and hundreds of thousands of users have reported no significant adverse effects.Suitable for Long-Term Use: Can be used as long as needed for weight management, unlike some weight loss drugs that are only approved for short-term use.No Habit-Forming Ingredients: Unlike some prescription appetite suppressants, PhenQ is non-addictive and safe for ongoing use.Made in FDA & GMP Approved Facilities: All manufacturing is done under strict quality controls in the US and UK. Scientific Innovation of OTC Weight Loss Supplements

What makes PhenQ a leader among OTC appetite suppressants and diet pills?

Multi-Action Formula: Combines the strongest ingredients for appetite control, fat burning, energy, and mood-unlike most other weight loss supplements that target a single aspect.α-Lacys Reset®: A unique, trademarked, and scientifically validated ingredient at the heart of PhenQ’s effectiveness.Synergy of Ingredients: Each component supports the others for a holistic approach to appetite suppression and weight management.Transparency: Full ingredient disclosure and clinical research citations-no hidden blends or proprietary secrets. OTC Diet Pills Market Disruption

PhenQ is fundamentally disrupting the appetite suppressant and weight loss supplement industry:

Medically Studied by 800 Professionals: PhenQ’s “clinicians’ choice” status is nearly impossible to attain and sets a new bar for OTC appetite suppressant pills.Outperforms Prescription Appetite Suppressants: Without the need for a prescription or risk of high blood pressure and other side effects, PhenQ is safer and more accessible.Superior to Traditional Diet Pills: PhenQ’s multi-pronged formula makes it more effective than many single-purpose appetite suppressant pills or dietary supplements.No Prescription, No Hassle: PhenQ brings prescription-level results to the OTC market-no waiting rooms, no doctor’s approval necessary. Consumer Benefits

Users of PhenQ enjoy a wide range of benefits-making it the strongest and most trusted OTC appetite suppressant available:

Strongest Appetite Suppressant OTC: Clinically proven to suppress appetite, crush cravings, and help users lose weight effectively.Promotes Weight Loss: Helps reduce calorie intake, supports fat burning, and assists in lowering body weight and body mass index.Appetite Control and Satiety: Natural ingredients help users feel full, satisfied, and in control of their eating habits.Counter Appetite and Emotional Eating: Reduces stress-related snacking and helps break the cycle of emotional eating.Supports Healthy Weight Management: Sustained use assists in long-term maintenance of healthy weight, reducing the risk of regaining lost pounds.Safe for Most Adults: No major side effects, no habit-forming components, and suitable for both men and women.Fits Modern Lifestyles: Only two pills per day, no drastic diet changes required, and works with keto and other popular diets.Money-Back Guarantee: If you’re not satisfied, get a full refund within 60 days-no questions asked. Quote from PhenQ Spokesperson

“PhenQ is the result of years of scientific research and clinical study. To be named a clinicians’ choice by over 800 medical professionals is an extraordinary honor-and a testament to our commitment to safety, effectiveness, and transparency. As the strongest OTC appetite suppressant available today, PhenQ is helping people in the USA and around the world take control of their appetite, lose weight safely, and achieve lasting health.”

– Kay Norris, Product Innovation, PhenQ

Distribution Channels

Direct-to-Consumer: Only available from the official site to guarantee authenticity and best pricing.Worldwide Shipping: To over 190 countries, with free shipping on orders over $79.99.Discreet Packaging: All orders shipped in plain packaging for your privacy. Website URL & Contact Person Details

Website: https://phenq.com/pages/appetite-suppressantEmail: [email protected]: +1 (646) 513 2632 For media inquiries:

Wolfson Brands (UK) Limited

12 Payne Street, Glasgow, G4 0LF, United Kingdom

[email protected]

Safety Certifications & Testing

FDA & GMP Approved Facilities: Manufactured to the highest US and UK standards.Third-Party Lab Testing: For purity, potency, and safety.Full Ingredient Transparency: No hidden blends or undisclosed substances.Vegan & Vegetarian Safe: 100% plant-based ingredients. Product Usage & Dosage

Recommended Use: Take one PhenQ pill with breakfast and one with lunch.Do Not Exceed Recommended Dose: Due to natural caffeine content, avoid taking after 3pm.Long-Term Use: Safe for ongoing appetite control and weight management. Appetite Suppressants in the Modern Age: How PhenQ Changes the Game

Appetite suppressants work by helping users feel full, reduce food cravings, and lower overall calorie intake. However, most prescription appetite suppressants and weight loss drugs come with potential side effects, high blood pressure risks, and often require strict medical supervision. OTC appetite suppressants like PhenQ are changing this landscape by providing a safe, effective, and accessible solution for Americans struggling with weight management.

PhenQ’s unique composition of scientifically proven ingredients sets it apart from alli weight loss pill and other common dietary supplements. It is not just a diet pill; it is a comprehensive, medically endorsed appetite suppressant designed to suppress cravings, promote weight loss, and support lasting health.

Conclusion: The Future of Appetite Control Is Here

PhenQ is the strongest appetite suppressant over the counter now available in the USA and worldwide-backed by 800 medical professionals and trusted by nearly 200,000 satisfied customers. With its powerful, natural appetite suppressant formula, robust clinical validation, and unmatched safety profile, PhenQ is setting a new standard for OTC appetite suppressants and weight management.

About PhenQ (USA) / Wolfson Brands

PhenQ is produced by Wolfson Brands, a global leader in health innovation. With a focus on science, safety, and customer success, PhenQ continues to redefine what’s possible in appetite suppressant pills and weight loss supplements.

Media Contact:

Kay Norris, Head of Product Innovation

Wolfson Brands (UK) Limited

12 Payne Street, Glasgow, G4 0LF, United Kingdom

[email protected]

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a physician before use.

Attachment

Phenq CONTACT:

For media inquiries:

Website: https://phenq.com/pages/appetite-suppressant

Email: [email protected]

Phone: +1 (646) 513 2632

Wolfson Brands (UK) Limited

12 Payne Street, Glasgow, G4 0LF, United Kingdom

[email protected]



Source link

Read More
30 06, 2025

Dogecoin (DOGE) Price Prediction: Dogecoin Builds Momentum Above $0.17 as Falling Wedge Signals Bullish Reversal

By |2025-06-30T23:24:59+03:00June 30, 2025|Crypto News, News|0 Comments

Dogecoin builds bullish momentum above $0.17 as a falling wedge pattern signals a breakout. Explore the latest Dogecoin price prediction and key support levels.

Dogecoin is showing early signs of a bullish reversal after weeks of consolidation. Backed by a breakout from a falling wedge pattern and improving technical indicators, DOGE has started to regain market traction, trading above $0.17 at press time.

This move has triggered cautious optimism among traders who believe a bigger move could be in play.

Dogecoin Price Today Shows Promising Upside Signals

The dogecoin price climbed 2.49% in the last 24 hours, reaching $0.1675, with a 65% surge in trading volume. Despite a 30% drop over the past month, the token has stabilized and moved back into a tighter range. Analysts note that Dogecoin is attempting to break above a key descending trendline, which historically signals a shift in market sentiment.

Dogecoin (DOGE) was trading at around $0.17, up 2.97% in the last 24 hours at press time. Source: Brave New Coin

Currently, dogecoin price prediction models suggest that this recovery could be gaining traction as technical strength builds. The Relative Strength Index (RSI) has rebounded from oversold levels, sitting around 44. A rise above 50 would indicate improving momentum.

Technical Setup: Falling Wedge Pattern Strengthens Dogecoin Forecast

A key catalyst behind the recent bullish sentiment is the emergence of a falling wedge pattern—a technical structure often associated with reversals. This pattern, confirmed by historical price action and trading volume, suggests a potential breakout is underway. DOGE has bounced multiple times off its $0.15 support zone, a level that has historically attracted buyer accumulation.

Dogecoin (DOGE) Price Prediction: Dogecoin Builds Momentum Above alt=

Dogecoin’s daily chart shows a bullish MACD crossover, indicating potential upward momentum for $DOGE. Source: Trader Tardigrade via X

Technical analysis shows the coin trading near the wedge’s upper boundary, testing the $0.1690 resistance level. A daily close above this zone could propel the dogecoin price toward the $0.1819 and $0.2018 Fibonacci retracement areas. The RSI currently hovers near 44 and is rebounding, signaling increasing buying pressure.

Derivatives Data Reinforces Bullish Bias

Derivatives market metrics paint a similarly optimistic picture. Open interest in Dogecoin futures has climbed 4.39% to $1.84 billion, while spot trading volume surged nearly 44%, indicating rising trader engagement. Additionally, options volume exploded by over 200%, suggesting that traders are positioning for a major move.

The 24-hour Long/Short Ratio sits at 1.0313 overall, but on Binance and OKX, the ratios are far more aggressive, exceeding 2.5 and reaching 3.11 on Binance alone. This tilt toward long positions indicates confidence in a potential breakout, but it also raises the risk of a sharp correction if price momentum falters.

Liquidation data further supports this bullish tilt. Over $2.2 million in short positions were liquidated recently, highlighting that bearish traders may be getting squeezed as DOGE continues to test higher levels.

Historical Wedges Suggest Explosive Moves

Dogecoin has a notable history of following through on falling wedge breakouts. In previous cycles, such formations have led to price surges ranging from 88% to over 400%. The current setup mirrors similar patterns, with the price of Dogecoin showing resilience above the $0.15 mark and attempting to breach the key resistance near $0.17.

Jonathan Carter

Dogecoin is rebounding from the lower support of a daily descending triangle, with a breakout above $0.17 potentially driving prices toward $0.20, $0.26, $0.31, and $0.39. Source: Jonathan Carter via X

Analyst Jonathan Carter emphasized this breakout potential, noting on social media that “Dogecoin is bouncing off the lower limit of support in a descending triangle pattern… A move above $0.17 could open the door to targets at $0.20, $0.26, $0.31, and $0.39.”

Whale Activity and On-Chain Signals

Recent on-chain data also indicates increased dogecoin whale activity. DOGE has experienced rising large transactions and a notable cooldown in liquidations. After a sharp leverage flush in May, liquidation dominance has fallen to just 6%—a sign that the market is stabilizing and may be entering a new accumulation phase.

Coinglass

DOGE OI-Weighted Funding Rate chart. Source: Coinglass

Besides, the current setup can be a disguised bear trap. Although there have been numerous spoof breakouts during the past few months, the fundamental indicators currently point to a superior setup, with strategic buying reportedly underway as bulls fight to preserve key support levels.

Outlook: Breakout or Continuation?

  • Bullish Scenario: A clean breakout above $0.1690, with reversal of $0.1749 to support, might take DOGE to the $0.2018 level, with extensions to $0.2463 if supported by volume.
  • Bearish Scenario: A drop below $0.15 may break the wedge pattern and expose the price to bearish risk down to $0.1350.
  • Neutral Scenario: Sideways action continued between $0.15 and $0.17 as the market builds structure for a clean breakout or breakdown.

Will Dogecoin Hit $1?

One of the biggest questions in the crypto space is, will Dogecoin hit $1? While the current setup doesn’t offer that guarantee, the technicals and price action favor a guarded optimism in the near future. A breakout above the wedge with confirmation in volume terms can be the starting point in that direction, but macroeconomic fundamentals and market sentiment will have important roles to play.

As one of the top meme coins, Dogecoin continues to serve as a barometer for retail market sentiment. Whale accumulation, rising open interest, and technical indicators all suggest that DOGE may be preparing for its next significant move.

Source link

Read More
30 06, 2025

Q&A About Endometrial Cancer Treatment Options

By |2025-06-30T22:35:42+03:00June 30, 2025|Fitness News, News|0 Comments

Endometrial cancer is cancer that forms in the lining of the uterus, which is called the endometrium. It is the fourth most common cancer for women in the United States and affects 1 in 50 women.

The good news? Doctors have many tools for treating endometrial cancer, and they work well, especially when the cancer is caught early. More than 80% of women diagnosed with endometrial cancer are alive five years later — and this number jumps to 95% if the cancer hasn’t spread outside the uterus.

Understanding the treatment options for endometrial cancer — including surgery, radiation and medication — can help you prepare for the road ahead. We spoke with Nita Lee, MD, associate professor of obstetrics and gynecology at the University of Chicago, about how endometrial cancer is treated.

What types of surgery are used for endometrial cancer?

These days, the most common surgery is minimally invasive (done through tiny cuts) laparoscopic or robotic surgery. We use this type of surgery for most endometrial cancer patients to remove the uterus and fallopian tubes and collect information about the lymph nodes.

If patients have more advanced disease that has spread to the lymph nodes or ovaries, or if the uterus is too large to do minimally invasive surgery, they may need to have open abdominal surgery.

What role does radiation therapy play in treating endometrial cancer?

Radiation therapy is most commonly used as an additional treatment after surgery. Care after surgery, called post-operative care, sometimes can involve radiation therapy based on certain findings at the time of surgery.

For example, if a person has certain risk factors in the uterus, their healthcare provider (HCP) might recommend they have vaginal radiation, or perhaps more involved pelvic radiation. Or if they have certain factors, such as cancer being found in the cervix after it was surgically removed, they may need radiation of the pelvic area.

Some patients with more advanced disease that involves the lymph nodes will get radiation in addition to chemotherapy. Occasionally, patients who are not eligible for surgery and who don’t want fertility-sparing treatment will get radiation only, but that’s fairly rare. It really varies depending on the patient.

What systemic (total body) treatments are used for endometrial cancer?

  • Chemotherapy is the backbone of treatment for patients diagnosed at an advanced stage. For example, if we find during surgery that a person has stage 3 or 4 cancer, they’ll often get chemotherapy as part of their post-surgery treatment plan.

People with stage 1 disease who have certain high-risk cell types also get chemotherapy after surgery.

  • Immunotherapy is a newer form of therapy. It’s similar to chemotherapy in that the medicine is given through an IV, but immunotherapy drugs work differently in the body.

While chemotherapy drugs typically act on the cancer cells themselves, immunotherapy is designed to help your body’s immune system attack the cancer.

One of the ways cancer cells get by your immune system is by hiding behind or making certain proteins so that your body doesn’t recognize the cancer cells as bad. Immunotherapy helps uncover the cancer.

Immunotherapy works best for certain categories of endometrial cancer, meaning it works better for some people than others. It’s been a game changer for recurrent endometrial cancer patients, as well as those who are diagnosed at an advanced stage.

  • Hormone therapy is used for endometrial cancers that are estrogen receptor– or progesterone receptor–positive, meaning the cancer cells contain receptors for estrogen or progesterone. We manipulate these receptors with hormones to try to treat the cancer.
  • Targeted therapy destroys cancer cells without harming other cells. Probably the most well known target is HER2, a protein we often hear about when we talk about breast cancer. Recent research shows a link between endometrial cancer and HER2, and targeted therapy can help.

Are there fertility-sparing treatments available for endometrial cancer?

Yes. Hormone therapy is the most common treatment for patients who are concerned about fertility. Usually we tend to limit fertility-sparing treatment to patients with stage 1 disease and those with lower-risk types of endometrial cancer (versus those with high-risk cell types).

What factors are considered when making treatment decisions?

A lot of our treatment decisions are based on the patient’s molecular profile, which looks at the tumor cells and the biomarkers and tells us exactly what type of endometrial cancer they have and whether the tumor will respond to certain treatments. We also look at any other health problems they may have and their goals for treatment, and we always want to balance quality of life.

This educational resource was created with support from Karyopharm.

From Your Site Articles

Related Articles Around the Web



Source link

Read More
30 06, 2025

XRP Ledger Launches Ethereum-Compatible Sidechain for DeFi Expansion

By |2025-06-30T21:37:25+03:00June 30, 2025|News, NFT News|0 Comments


The XRP Ledger has expanded its capabilities with the launch of an Ethereum-compatible sidechain, marking a significant development in the blockchain ecosystem. This new sidechain enables Ethereum-based smart contracts and cross-chain decentralized finance (DeFi) applications, leveraging XRP as its gas token. The integration allows developers to write smart contracts in Solidity, the programming language commonly used on Ethereum, while benefiting from the XRP Ledger’s established infrastructure, fast block times, and low transaction fees.

The sidechain, built by Peersyst with support from Ripple and the broader XRPL community, has been connected to over 80 blockchains through Axelar, a cross-chain connectivity provider. This connection facilitates cross-chain real-world asset (RWA) and DeFi applications, expanding the reach and utility of the XRP Ledger. The bridge, which went live simultaneously with the sidechain’s debut, provides developers with an immediate route to multiple blockchains and allows the sidechain to use wrapped XRP as its native gas token. This seamless integration is managed through a user-friendly interface run by Squid, eliminating the need for users to juggle multiple wallets and bridges.

The launch of the EVM-compatible sidechain opens up new opportunities for developers and institutions. More than six million XRP Ledger wallets are now just one click away from DeFi applications that were previously exclusive to Ethereum Virtual Machine (EVM) chains. Several projects have already begun to leverage this new capability. Strobe is introducing a money market for lending and over-collateralized borrowing, while Securd is offering a lending model that finances leveraged DeFi positions. Vertex, known for its derivatives engine, plans to bring capital-efficient trading to the network. Additionally, Blockscout is providing a block explorer, and Goldsky is handling indexing and data feeds.

The sidechain’s compatibility with EVM also provides a timely tool for institutions exploring tokenized dollars and other real-world assets. The XRP Ledger has long positioned itself as a platform for regulated finance, and its backers believe that EVM compatibility strengthens this position. David Schwartz, Ripple’s chief technology officer and one of the ledger’s original architects, highlighted that the sidechain allows teams to use familiar EVM tooling while drawing on XRP liquidity. Georgios Vlachos, who heads the Axelar Foundation, noted that banks and fintech firms are actively seeking reliable cross-chain rails, and this collaboration addresses that demand without altering the core XRP network.

Furthermore, Ripple has integrated Wormhole to enable the XRPL and its EVM sidechain to interact with over 35 blockchain networks, including Ethereum and Solana. This integration enhances the network’s utility by allowing developers to execute Ethereum-based smart contracts on the XRP Ledger, further expanding its capabilities. The sidechain also supports stablecoins like RLUSD and asset tokenization, broadening the ledger’s use cases beyond payments.

With the bridge live and early decentralized applications (dApps) moving in, the XRP Ledger steps into the multichain era. The network aims to differentiate itself through speed, low costs, and a growing list of compliant rails, positioning itself as a competitive player in an increasingly crowded field. This development underscores the XRP Ledger’s commitment to innovation and its potential to become a leading platform for cross-chain DeFi and real-world asset tokenization.



Source link

Read More
30 06, 2025

Natural Gas Price Outlook – Natural Gas Plummets in Early Monday Trading

By |2025-06-30T21:36:25+03:00June 30, 2025|Forex News, News|0 Comments


Scan QR code to install app

Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party’s services, and does not assume responsibility for your use of any such third party’s website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.Risk DisclaimersThis website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.



Source link

Read More
30 06, 2025

EUR/USD, USD/JPY and AUD/USD Forecast – US Dollar Continues to Look Mixed

By |2025-06-30T21:35:19+03:00June 30, 2025|Forex News, News|0 Comments

But if we can get above this 50 day EMA, perhaps we go climbing to the 148 yen level again, which is where the 200 day EMA sits, which is typically thought of as a major support resistance area. If we do break down below here, I see a somewhat important area in the range of 142 yen, but we’ll just have to see how that plays out. I still favor the upside simply because you get paid to wait.

AUD/USD Technical Analysis

And finally, taking a look at the Australian dollar, we continue to struggle with 0.6550. We’ve pulled back from there, yet again. We just cannot really take off to the upside and go looking to maybe 0.67 yet, despite the fact that the US dollar is weakening against multiple other currencies. But it appears to me that Pacific currencies, for example, the yen, the Australian dollar, the New Zealand dollar are all in the same boat, they just can’t launch against the greenback. So that tells me that most of what we’re seeing anti US dollar is a pro Europe, pro-UK type of situation.

For a look at all of today’s economic events, check out our economic calendar.

Source link

Read More
30 06, 2025

Branded Chocolate Protein Powders : C4 Whey Protein powder

By |2025-06-30T21:30:34+03:00June 30, 2025|Dietary Supplements News, News|0 Comments


C4 Whey Protein powder has debuted a new product in the UK as its first-ever whey protein supplement with a branded chocolate flavor in focus to satisfy consumer demand for indulgent yet lifestyle-conscious products.

The brand has entered into a partnership with The Hershey Company to debut two flavors including Hershey’s Milk Chocolate and Reese’s Peanut Butter & Chocolate. The protein powders each features 25-grams of whey protein to support muscle recovery, growth and performance, while also having no added sugars in the mix.

Chairman and CEO Doss Cunningham commented on the new C4 Whey Protein powders saying, “We prioritise listening to our customers and value our strategic partnerships. For years, users have been mixing their own peanut butter and chocolate protein shakes. After extensive testing, we’re thrilled to finally bring the debut of C4 Whey Protein in three mouth-watering flavours which fitness enthusiasts and chocolate lovers alike can enjoy.”



Source link

Read More
30 06, 2025

XRP Price Prediction: XRP Surges as $50M SEC Settlement Clears Path for ETF Hopes

By |2025-06-30T21:24:30+03:00June 30, 2025|Crypto News, News|0 Comments

XRP rallies after Ripple settles SEC case for $50M. Legal clarity boosts ETF speculation and institutional interest in XRP.

Written by:

Maham Arslan


•
Monday, June 30, 2025
•
2 min read

•
Last updated: Monday, June 30, 2025
















Register now to be able to add articles to your reading list.

” aria-hidden=”true”>

Quick overview

XRP rallies after Ripple settles SEC case for $50M. Legal clarity boosts ETF speculation and institutional interest in XRP.

XRP is holding steady near $2.18 after Ripple’s long-running legal battle with the U.S. Securities and Exchange Commission officially ended. Ripple (XRP) agreed to a $50 million settlement, which is quite lower than the initially anticipated $125 million. This closes the case and lifts the ban on institutional sales of XRP, injecting new life into market sentiment and investor confidence.

Brad Garlinghouse, Ripple’s CEO, called it a turning point: “We’re closing this chapter once and for all.”

With the lawsuit resolved and both parties dropping appeals, Ripple now has a clearer legal framework to re-engage institutional partners. This development not only supports XRP but also enhancing regulatory clarity across the broader crypto market.

  • $50M settlement finalized, far below projections
  • Institutional sales restriction lifted
  • Investor sentiment turning bullish

XRP ETF Buzz Grows Amid Regulatory Clarity

The resolution of Ripple’s legal uncertainty has triggered new optimism around the possibility of an XRP spot ETF. According to AIXBT, an AI-powered forecasting tool, July could be pivotal, with a predicted 5% price lift due to mounting ETF anticipation.

Nate Geraci of The ETF Store suggests that the cleared legal path makes XRP more appealing to issuers like BlackRock. Bloomberg analyst James Seyffart believes an XRP ETF could attract $85 million in assets during its first week, given XRP’s robust market capitalization, which is about 7.5% of Bitcoin’s.

For context, Bitcoin ETFs generated $14 billion in early trading volume and over $1 billion in inflows—setting a benchmark that XRP could partially mirror if an ETF is launched.

 

XRP/USD

Technical Outlook: XRP at a Critical Juncture

Technically, XRP/USD is trading just above an upward trendline support establishedablished since June 23. At the moment, XRP is intersecting with the 50-period EMA at $2.17. The pattern suggests tightening price action within a wedge, often a precursor to breakout volatility.

The chart shows:

  • Higher lows since $2.08 suggest bullish undercurrents
  • Resistance at $2.23 has capped price for several days
  • MACD shows mild bearish divergence, indicating waning momentum

XRP Price Prediction: XRP Surges as M SEC Settlement Clears Path for ETF Hopes

XRP Trade Setup:

  • Bullish bias: Buy near $2.17 support
    • Targets: $2.23 and $2.27
    • Stop: $2.08
  • Bearish bias: Sell below $2.17 on volume
    • Targets: $2.12 and $2.08
    • Stop: $2.23

With legal hurdles cleared and ETF momentum building, XRP remains a watchlist priority for institutional and retail investors alike.

Maham Arslan

Crypto News Writer | Blockchain & Web3 Reporter

Maham is a crypto news writer and market analyst specializing in breaking down the latest developments across blockchain, digital assets, and decentralized finance (DeFi). With hands-on experience covering high-impact stories—from regulatory shifts and token launches to macro-driven price movements—she delivers timely, accurate, and SEO-optimized content for fast-growing crypto media platforms.

Her expertise lies in producing daily news reports, price predictions, technical summaries, and coverage of market-moving events. Maham tracks real-time updates across global newswires, X (Twitter), and on-chain data to provide actionable insights tailored for retail traders, crypto enthusiasts, and institutional readers.

With a strong grasp of crypto fundamentals and Web3 trends, she delivers content that’s informed, accessible, and always on time.

Related Articles



Source link

Read More
30 06, 2025

Forecast update for Gold -30-06-2025

By |2025-06-30T19:35:22+03:00June 30, 2025|Forex News, News|0 Comments


Coffee price continued forming strong negative trading, to face 50%Fibonacci correctional level, which forms a strong support at 292.85, then bounces quickly towards 302.05 as appears in the above image.

 

We expect forming some mixed trading, but its repeated stability above the current support will  reinforce the chances for gathering the positive momentum and begin recovering the losses by targeting 313.60 level, reaching the barrier at 327.05.

 

The expected trading range for today is between 395.00 and 313.60

 

Trend forecast: Bullish





Source link

Read More
30 06, 2025

Euro stabilizes but clings to bullish bias

By |2025-06-30T19:34:21+03:00June 30, 2025|Forex News, News|0 Comments

  • EUR/USD fluctuates in a narrow channel above 1.1700 on Monday.
  • The near-term technical picture suggests that the bullish bias remains unchanged.
  • Comments from central bankers could trigger the next big action in the pair.

EUR/USD seems to have entered a consolidation phase above 1.1700 on Monday following the previous week’s impressive rally.

Euro PRICE This month

The table below shows the percentage change of Euro (EUR) against listed major currencies this month. Euro was the strongest against the Japanese Yen.

USD EUR GBP JPY CAD AUD NZD CHF
USD -2.95% -1.39% 0.13% -0.98% -1.46% -1.66% -3.11%
EUR 2.95% 1.64% 3.15% 2.04% 1.58% 1.66% -0.16%
GBP 1.39% -1.64% 1.50% 0.40% -0.05% -0.15% -1.76%
JPY -0.13% -3.15% -1.50% -1.12% -1.52% -1.66% -3.19%
CAD 0.98% -2.04% -0.40% 1.12% -0.41% -0.56% -2.15%
AUD 1.46% -1.58% 0.05% 1.52% 0.41% 0.08% -1.71%
NZD 1.66% -1.66% 0.15% 1.66% 0.56% -0.08% -1.79%
CHF 3.11% 0.16% 1.76% 3.19% 2.15% 1.71% 1.79%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).

While the technical outlook remains bullish in the near term, investors could refrain from taking large positions ahead of European Central Bank (ECB) President Christine Lagarde’s and Federal Reserve (Fed) Chairman Jerome Powell’s speeches at the ECB Forum on Central Banking on Tuesday.

Lagarde and Powell will participate in a policy panel. According to the CME FedWatch Tool, markets are currently pricing in about a 20% probability of the Fed lowering the policy rate by 25 basis points at the July meeting. This market positioning suggests that the US Dollar (USD) could stay resilient against its peers in case Powell reaffirms that they are unlikely to ease the policy until September.

The data from Germany showed on Monday that annual inflation, as measured by the change in the Consumer Price Index (CPI), edged lower to 2% in June’s preliminary estimate from 2.1% in May. On a monthly basis, the CPI remained unchanged. This reading came in below the market expectation for an increase of 0.2% and made it difficult for the Euro to gather strength.

Meanwhile, Wall Street’s main indexes started the day in positive territory, not allowing the USD to gather recovery momentum and helping EUR/USD limit its downside.

Later in the day, EUR/USD’s could experience heightened volatility due to position adjustments and profit-taking on the last day of the second quarter.

EUR/USD Technical Analysis

EUR/USD fluctuates within the upper half of the ascending regression channel and the Relative Strength Index (RSI) indicator on the 4-hour chart holds above 60, despite retreating slightly in the first half of the day. On the upside, 1.1730 (static level) aligns as an interim resistance level before 1.1760 (upper limit of the ascending channel) and 1.1800 (static level, round level).

In case EUR/USD fails to hold above 1.1700 (static level, 20-period Simple Moving Average) and flips that level into resistance, 1.1660 (mid-point of the ascending channel) and 1.1620 (static level) could be seen as next support levels.

Euro FAQs

The Euro is the currency for the 19 European Union countries that belong to the Eurozone. It is the second most heavily traded currency in the world behind the US Dollar. In 2022, it accounted for 31% of all foreign exchange transactions, with an average daily turnover of over $2.2 trillion a day.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed by EUR/JPY (4%), EUR/GBP (3%) and EUR/AUD (2%).

The European Central Bank (ECB) in Frankfurt, Germany, is the reserve bank for the Eurozone. The ECB sets interest rates and manages monetary policy.
The ECB’s primary mandate is to maintain price stability, which means either controlling inflation or stimulating growth. Its primary tool is the raising or lowering of interest rates. Relatively high interest rates – or the expectation of higher rates – will usually benefit the Euro and vice versa.
The ECB Governing Council makes monetary policy decisions at meetings held eight times a year. Decisions are made by heads of the Eurozone national banks and six permanent members, including the President of the ECB, Christine Lagarde.

Eurozone inflation data, measured by the Harmonized Index of Consumer Prices (HICP), is an important econometric for the Euro. If inflation rises more than expected, especially if above the ECB’s 2% target, it obliges the ECB to raise interest rates to bring it back under control.
Relatively high interest rates compared to its counterparts will usually benefit the Euro, as it makes the region more attractive as a place for global investors to park their money.

Data releases gauge the health of the economy and can impact on the Euro. Indicators such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can all influence the direction of the single currency.
A strong economy is good for the Euro. Not only does it attract more foreign investment but it may encourage the ECB to put up interest rates, which will directly strengthen the Euro. Otherwise, if economic data is weak, the Euro is likely to fall.
Economic data for the four largest economies in the euro area (Germany, France, Italy and Spain) are especially significant, as they account for 75% of the Eurozone’s economy.

Another significant data release for the Euro is the Trade Balance. This indicator measures the difference between what a country earns from its exports and what it spends on imports over a given period.
If a country produces highly sought after exports then its currency will gain in value purely from the extra demand created from foreign buyers seeking to purchase these goods. Therefore, a positive net Trade Balance strengthens a currency and vice versa for a negative balance.

Source link

Read More
Go to Top